VolitionRx Limited Financing Cash Flow
VolitionRx Limited (VNRX) reported Financing Cash Flow of $12.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- VolitionRx Limited net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $4.98M, a 12.19% decline year-over-year.
- VolitionRx Limited net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $7.62M, a 107.69% increase year-over-year.
- VolitionRx Limited net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $6.16M, a 168.83% increase year-over-year.
- VolitionRx Limited net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.60M, a 71.45% decline year-over-year.
- VolitionRx Limited net cash provided by (used in) financing activities for fiscal 2025 was $17.09M, a 97.44% increase from fiscal 2024.
- VolitionRx Limited net cash provided by (used in) financing activities for fiscal 2024 was $8.66M, a 70.13% decline from fiscal 2023.
- VolitionRx Limited net cash provided by (used in) financing activities for fiscal 2023 was $28.98M, a 317.74% increase from fiscal 2022.
- VolitionRx Limited net cash provided by (used in) financing activities for fiscal 2022 was $6.94M, a 69.65% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 5 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed | Net Cash Provided by (Used in) Financing Activities 17 month | Net Cash Provided by (Used in) Financing Activities 20 month | Net Cash Provided by (Used in) Financing Activities 23 month | Net Cash Provided by (Used in) Financing Activities 26 month | Net Cash Provided by (Used in) Financing Activities 29 month | Net Cash Provided by (Used in) Financing Activities 32 month | Net Cash Provided by (Used in) Financing Activities 35 month | Net Cash Provided by (Used in) Financing Activities 38 month | Net Cash Provided by (Used in) Financing Activities 41 month | Net Cash Provided by (Used in) Financing Activities 44 month | Net Cash Provided by (Used in) Financing Activities 47 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $12.60M 10-Q · filed 2026-08-13 | $18.75M derived: sum of 3 quarters · filed 2026-08-13 | $20.35M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2026-03-31 | $7.62M 10-Q · filed 2026-05-14 | $13.77M derived: sum of 2 quarters · filed 2026-05-14 | $15.37M derived: sum of 3 quarters · filed 2026-05-14 | $21.04M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-12-31 | $6.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.76M derived: sum of 2 quarters · filed 2026-03-31 | $13.43M derived: sum of 3 quarters · filed 2026-08-13 | $17.09M 10-K · filed 2026-03-31 | ||||||||||||||||
| 2025-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $7.27M derived: sum of 2 quarters · filed 2026-08-13 | $10.94M 10-Q · filed 2025-11-13 | $13.23M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-06-30 | $5.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $9.34M 10-Q · filed 2026-08-13 | $11.63M derived: sum of 3 quarters · filed 2026-08-13 | $17.23M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-03-31 | $3.67M 10-Q · filed 2026-05-14 | $5.96M derived: sum of 2 quarters · filed 2026-05-14 | $11.56M derived: sum of 3 quarters · filed 2026-05-14 | $12.53M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||||||||
| 2024-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.89M derived: sum of 2 quarters · filed 2026-03-31 | $8.87M derived: sum of 3 quarters · filed 2026-03-31 | $8.66M 10-K · filed 2026-03-31 | ||||||||||||||||
| 2024-09-30 | $5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $6.58M derived: sum of 2 quarters · filed 2025-11-13 | $6.37M 10-Q · filed 2025-11-13 | $10.14M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||||||
| 2024-06-30 | $973.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $764.04K 10-Q · filed 2025-08-14 | $4.53M derived: sum of 3 quarters · filed 2025-08-14 | $4.26M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||||
| 2024-03-31 | -$209.40K 10-Q · filed 2025-05-15 | $3.56M derived: sum of 2 quarters · filed 2025-05-15 | $3.29M derived: sum of 3 quarters · filed 2025-05-15 | $20.63M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||||||
| 2023-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.50M derived: sum of 2 quarters · filed 2025-03-31 | $20.84M derived: sum of 3 quarters · filed 2025-03-31 | $28.98M 10-K · filed 2025-03-31 | ||||||||||||||||
| 2023-09-30 | -$274.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $17.07M derived: sum of 2 quarters · filed 2024-11-14 | $25.21M 10-Q · filed 2024-11-14 | $26.14M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||||||
| 2023-06-30 | $17.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $25.49M 10-Q · filed 2024-08-14 | $26.41M derived: sum of 3 quarters · filed 2024-08-14 | $33.14M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||||||
| 2023-03-31 | $8.15M 10-Q · filed 2024-05-13 | $9.07M derived: sum of 2 quarters · filed 2024-05-13 | $15.80M derived: sum of 3 quarters · filed 2024-05-13 | $15.34M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||||||||||
| 2022-12-31 | $925.96K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $7.65M derived: sum of 2 quarters · filed 2024-03-25 | $7.19M derived: sum of 3 quarters · filed 2024-03-25 | $6.94M 10-K · filed 2024-03-25 | ||||||||||||||||
| 2022-09-30 | $6.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $6.27M derived: sum of 2 quarters · filed 2023-11-14 | $6.01M 10-Q · filed 2023-11-14 | $6.63M 10-Q · filed 2022-11-14 | $8.11M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | -$460.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$714.58K 10-Q · filed 2023-08-14 | -$94.03K 10-Q · filed 2022-08-10 | $1.38M derived: sum of 3 quarters · filed 2023-08-14 | $1.43M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||||
| 2022-03-31 | -$254.38K 10-Q · filed 2023-05-10 | $366.17K 10-Q · filed 2022-05-11 | $1.84M derived: sum of 2 quarters · filed 2023-05-10 | $1.89M derived: sum of 3 quarters · filed 2023-05-10 | $2.39M derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||||
| 2021-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $2.15M derived: sum of 2 quarters · filed 2023-03-15 | $2.65M derived: sum of 3 quarters · filed 2023-03-15 | $22.86M 10-K · filed 2023-03-15 | ||||||||||||||||
| 2021-09-30 | $50.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $551.79K derived: sum of 2 quarters · filed 2022-11-14 | $20.76M 10-Q · filed 2022-11-14 | $22.90M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||||||
| 2021-06-30 | $501.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $20.71M 10-Q · filed 2022-08-10 | $22.85M derived: sum of 3 quarters · filed 2022-08-10 | $27.45M derived: sum of 4 quarters · filed 2022-08-10 | ||||||||||||||||
| 2021-03-31 | $20.21M 10-Q · filed 2022-05-11 | $22.35M derived: sum of 2 quarters · filed 2022-05-11 | $26.95M derived: sum of 3 quarters · filed 2022-05-11 | $41.03M derived: sum of 4 quarters · filed 2022-05-11 | ||||||||||||||||
| 2020-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $6.74M derived: sum of 2 quarters · filed 2022-03-30 | $20.82M derived: sum of 3 quarters · filed 2022-03-30 | $20.62M 10-K · filed 2022-03-30 | ||||||||||||||||
| 2020-09-30 | $4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $18.68M derived: sum of 2 quarters · filed 2021-11-10 | $18.48M 10-Q · filed 2021-11-10 | $19.02M derived: sum of 4 quarters · filed 2021-11-10 | ||||||||||||||||
| 2020-06-30 | $14.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $13.88M 10-Q · filed 2021-08-11 | $14.41M derived: sum of 3 quarters · filed 2021-08-11 | $19.05M derived: sum of 4 quarters · filed 2021-08-11 | ||||||||||||||||
| 2020-03-31 | -$202.09K 10-Q · filed 2021-05-11 | $332.55K derived: sum of 2 quarters · filed 2021-05-11 | $4.97M derived: sum of 3 quarters · filed 2021-05-11 | $10.16M derived: sum of 4 quarters · filed 2021-05-11 | ||||||||||||||||
| 2019-12-31 | $534.64K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $5.17M derived: sum of 2 quarters · filed 2021-03-22 | $10.36M derived: sum of 3 quarters · filed 2021-03-22 | $16.93M 10-K · filed 2021-03-22 | ||||||||||||||||
| 2019-09-30 | $4.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $9.82M derived: sum of 2 quarters · filed 2020-11-12 | $16.39M 10-Q · filed 2020-11-12 | $17.03M derived: sum of 4 quarters · filed 2020-11-12 | ||||||||||||||||
| 2019-06-30 | $5.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $11.76M 10-Q · filed 2020-08-13 | $11.76M 10-Q · filed 2019-08-12 | $12.39M derived: sum of 3 quarters · filed 2020-08-13 | $21.50M derived: sum of 4 quarters · filed 2020-08-13 | |||||||||||||||
| 2019-03-31 | $6.57M 10-Q · filed 2020-05-07 | $7.20M derived: sum of 2 quarters · filed 2020-05-07 | $16.31M derived: sum of 3 quarters · filed 2020-05-07 | $16.81M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||||||||
| 2018-12-31 | $633.37K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $9.74M derived: sum of 2 quarters · filed 2020-02-20 | $10.24M derived: sum of 3 quarters · filed 2020-02-20 | $17.97M 10-K · filed 2020-02-20 | ||||||||||||||||
| 2018-09-30 | $9.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $9.61M derived: sum of 2 quarters · filed 2019-11-12 | $17.33M 10-Q · filed 2019-11-12 | $17.56M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||||
| 2018-06-30 | $500.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $8.23M 10-Q · filed 2019-08-12 | $8.45M derived: sum of 3 quarters · filed 2019-08-12 | $8.75M derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||||||||
| 2018-03-31 | $7.72M 10-Q · filed 2019-05-08 | $7.95M derived: sum of 2 quarters · filed 2019-05-08 | $8.25M derived: sum of 3 quarters · filed 2019-05-08 | $9.39M derived: sum of 4 quarters · filed 2019-05-08 | ||||||||||||||||
| 2017-12-31 | $222.99K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $522.33K derived: sum of 2 quarters · filed 2019-03-13 | $1.67M derived: sum of 3 quarters · filed 2019-03-13 | $1.97M 10-K · filed 2019-03-13 | ||||||||||||||||
| 2017-09-30 | $299.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.44M derived: sum of 2 quarters · filed 2018-11-07 | $1.74M 10-Q · filed 2018-11-07 | $13.52M derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||||||||
| 2017-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $1.44M 10-Q · filed 2018-08-13 | $13.23M derived: sum of 3 quarters · filed 2018-08-13 | $13.37M derived: sum of 4 quarters · filed 2018-08-13 | ||||||||||||||||
| 2017-03-31 | $301.09K 10-Q · filed 2018-05-10 | $12.08M derived: sum of 2 quarters · filed 2018-05-10 | $12.23M derived: sum of 3 quarters · filed 2018-05-10 | $12.25M derived: sum of 4 quarters · filed 2018-05-10 | ||||||||||||||||
| 2016-12-31 | $11.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $11.93M derived: sum of 2 quarters · filed 2018-03-01 | $11.95M derived: sum of 3 quarters · filed 2018-03-01 | $25.19M 10-K · filed 2018-03-01 | $25.38M 10-K · filed 2017-03-10 | |||||||||||||||
| 2016-09-30 | $145.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $171.28K derived: sum of 2 quarters · filed 2017-11-09 | $13.41M 10-Q · filed 2017-11-09 | $13.43M 10-Q · filed 2016-11-10 | $14.56M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||||
| 2016-06-30 | $25.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $13.26M 10-Q · filed 2017-08-10 | $14.41M derived: sum of 3 quarters · filed 2017-08-10 | $14.29M derived: sum of 4 quarters · filed 2017-08-10 | ||||||||||||||||
| 2016-03-31 | $13.24M 10-Q · filed 2017-05-11 | $14.38M derived: sum of 2 quarters · filed 2017-05-11 | $14.26M derived: sum of 3 quarters · filed 2017-05-11 | $14.48M derived: sum of 4 quarters · filed 2017-05-11 | ||||||||||||||||
| 2015-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $1.03M derived: sum of 2 quarters · filed 2017-03-10 | $1.24M derived: sum of 3 quarters · filed 2017-03-10 | $12.44M 10-K · filed 2017-03-10 | $12.88M 10-K · filed 2016-03-11 | |||||||||||||||
| 2015-09-30 | -$121.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $91.28K derived: sum of 2 quarters · filed 2016-11-10 | $11.29M 10-Q · filed 2016-11-10 | $11.70M 10-Q · filed 2015-11-04 | $12.03M derived: sum of 4 quarters · filed 2016-11-10 | |||||||||||||||
| 2015-06-30 | $212.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $11.42M 10-Q · filed 2016-08-11 | $12.15M derived: sum of 3 quarters · filed 2016-08-11 | $13.89M derived: sum of 4 quarters · filed 2016-08-11 | ||||||||||||||||
| 2015-03-31 | $11.20M 10-Q · filed 2016-05-13 | $11.94M derived: sum of 2 quarters · filed 2016-05-13 | $13.68M derived: sum of 3 quarters · filed 2016-05-13 | $14.03M derived: sum of 4 quarters · filed 2016-05-13 | ||||||||||||||||
| 2014-12-31 | $733.42K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $2.47M derived: sum of 2 quarters · filed 2016-03-11 | $2.83M derived: sum of 3 quarters · filed 2016-03-11 | $5.74M 10-K · filed 2016-03-11 | ||||||||||||||||
| 2014-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $2.09M derived: sum of 2 quarters · filed 2015-11-04 | $5.00M 10-Q · filed 2015-11-04 | $6.12M derived: sum of 4 quarters · filed 2015-11-04 | ||||||||||||||||
| 2014-06-30 | $352.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $3.26M 10-Q · filed 2015-08-11 | $4.38M derived: sum of 3 quarters · filed 2015-08-11 | $4.92M derived: sum of 4 quarters · filed 2015-08-11 | $11.54M 10-Q · filed 2014-08-01 | |||||||||||||||
| 2014-03-31 | $2.91M 10-Q · filed 2015-05-12 | $4.03M derived: sum of 2 quarters · filed 2015-05-12 | $4.57M derived: sum of 3 quarters · filed 2015-05-12 | $5.91M derived: sum of 4 quarters · filed 2015-05-12 | $11.19M 10-Q · filed 2014-05-15 | |||||||||||||||
| 2013-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $1.66M derived: sum of 2 quarters · filed 2015-03-18 | $3.00M derived: sum of 3 quarters · filed 2015-03-18 | $3.59M 10-K · filed 2015-03-18 | $8.28M 10-K · filed 2014-03-28 | |||||||||||||||
| 2013-09-30 | $537.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.88M derived: sum of 2 quarters · filed 2014-11-06 | $2.48M 10-Q · filed 2014-11-06 | $3.00M derived: sum of 4 quarters · filed 2014-11-06 | $7.30M 10-Q · filed 2013-10-31 | |||||||||||||||
| 2013-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $1.94M 10-Q · filed 2014-08-01 | $2.46M derived: sum of 3 quarters · filed 2014-08-01 | $3.12M derived: sum of 4 quarters · filed 2014-08-01 | $6.76M 10-Q · filed 2013-07-29 | |||||||||||||||
| 2013-03-31 | $594.68K 10-Q · filed 2014-05-15 | $1.12M derived: sum of 2 quarters · filed 2014-05-15 | $1.78M derived: sum of 3 quarters · filed 2014-05-15 | $2.59M derived: sum of 4 quarters · filed 2014-05-15 | $5.41M 10-Q · filed 2013-05-06 | |||||||||||||||
| 2012-12-31 | $522.19K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $1.19M derived: sum of 2 quarters · filed 2014-03-28 | $1.99M derived: sum of 3 quarters · filed 2014-03-28 | $2.47M 10-K · filed 2014-03-28 | $4.68M 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | $664.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.47M derived: sum of 2 quarters · filed 2013-10-31 | $1.95M 10-Q · filed 2013-10-31 | $1.92M derived: sum of 4 quarters · filed 2013-10-31 | $4.20M 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | $808.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $1.29M 10-Q · filed 2013-07-29 | $1.25M derived: sum of 3 quarters · filed 2013-07-29 | $2.41M derived: sum of 4 quarters · filed 2013-07-29 | $3.53M 10-Q · filed 2012-08-14 | |||||||||||||||
| 2012-03-31 | $479.25K 10-Q · filed 2013-05-06 | $445.72K derived: sum of 2 quarters · filed 2013-05-06 | $1.60M derived: sum of 3 quarters · filed 2013-05-06 | $1.61M derived: sum of 4 quarters · filed 2013-05-06 | $2.72M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | -$33.53K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $1.12M derived: sum of 2 quarters · filed 2013-04-01 | $1.14M derived: sum of 3 quarters · filed 2013-04-01 | $1.98M 10-K · filed 2013-04-01 | $2.02M 10-KT/A · filed 2012-05-08 | $2.24M 10-KT/A · filed 2012-05-08 | ||||||||||||||
| 2011-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $1.17M derived: sum of 2 quarters · filed 2012-11-14 | $2.02M 10-Q · filed 2012-11-14 | |||||||||||||||||
| 2011-06-30 | $11.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $859.66K 10-Q · filed 2012-08-14 | ||||||||||||||||||
| 2011-03-31 | $847.75K 10-Q · filed 2012-05-15 | |||||||||||||||||||
| 2010-12-31 | $227.26K 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |